Abbott Laboratories (ABT) Work In Process (2009 - 2026)

Abbott Laboratories' Work In Process history runs 18 years deep, the most recent figure standing at $994.0 million for Q1 2026.

• In Q1 2026, Work In Process rose 11.69% year-over-year to $994.0 million; the TTM figure through Mar 2026 stood at $994.0 million (up 11.69% YoY), while the FY2025 annual figure was $904.0 million, up 7.62% from the prior year.
• Work In Process came in at $994.0 million for Q1 2026 at Abbott Laboratories, up from $904.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $994.0 million in Q1 2026 to a low of $680.0 million in Q4 2022.
• A 5-year average of $843.8 million and a median of $877.0 million in 2024 frame the typical range for Work In Process.
• Across the five-year window, Work In Process declined 10.8% in 2022 and rose 22.31% in 2023, its largest moves.
• Abbott Laboratories' Work In Process stood at $680.0 million in 2022, then increased by 18.68% to $807.0 million in 2023, then increased by 4.09% to $840.0 million in 2024, then increased by 7.62% to $904.0 million in 2025, then advanced by 9.96% to $994.0 million in 2026.
• According to Business Quant data, Work In Process over the past three periods registered $994.0 million, $904.0 million, and $961.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison